{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:18:03Z","timestamp":1774070283549,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10815-021-02185-2","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T20:05:40Z","timestamp":1618344340000},"page":"1799-1807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Minimal ovarian stimulation is an alternative to conventional protocols for older women according to Poseidon\u2019s stratification: a retrospective multicenter cohort study"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5929-2357","authenticated-orcid":false,"given":"Mauro","family":"Cozzolino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Nardini","family":"Cecchino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Antonio","family":"Garcia-Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol\u00e1s","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,13]]},"reference":[{"issue":"6","key":"2185_CR1","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.rbmo.2018.12.030","volume":"38","author":"J Errazuriz","year":"2019","unstructured":"Errazuriz J, Drakopoulos P, Pening D, Racca A, Romito A, De Munck N, et al. Pituitary suppression protocol among Bologna poor responders undergoing ovarian stimulation using corifollitropin alfa: does it play any role? Reprod BioMed Online. 2019;38(6):1010\u20137.","journal-title":"Reprod BioMed Online"},{"issue":"3","key":"2185_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/GCO.0000000000000452","volume":"30","author":"A Vaiarelli","year":"2018","unstructured":"Vaiarelli A, Cimadomo D, Ubaldi N, Rienzi L, Ubaldi FM. What is new in the management of poor ovarian response in IVF? Curr Opin Obstet Gynecol. 2018 Jun;30(3):155\u201362.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"7","key":"2185_CR3","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L, et al. ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616\u201324.","journal-title":"Hum Reprod"},{"issue":"3","key":"2185_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/humupd\/dmw001","volume":"22","author":"A Papathanasiou","year":"2016","unstructured":"Papathanasiou A, Searle BJ, King NM, Bhattacharya S. Trends in \u2018poor responder\u2019 research: lessons learned from RCTs in assisted conception. Hum Reprod Update. 2016;22(3):306\u201319.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2185_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.fertnstert.2017.09.024","volume":"109","author":"A Boza","year":"2018","unstructured":"Boza A, Oguz SY, Misirlioglu S, Yakin K, Urman B. Utilization of the Bologna criteria: a promise unfulfilled? A review of published and unpublished\/ongoing trials. Fertil Steril. 2018;109(1):104\u2013109.e2.","journal-title":"Fertil Steril"},{"issue":"9","key":"2185_CR6","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1093\/humrep\/deu138","volume":"29","author":"CA Venetis","year":"2014","unstructured":"Venetis CA. The Bologna criteria for poor ovarian response: the good, the bad and the way forward. Hum Reprod. 2014;29(9):1839\u201341.","journal-title":"Hum Reprod"},{"issue":"6","key":"2185_CR7","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","volume":"105","author":"C Alviggi","year":"2016","unstructured":"Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number), Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105(6):1452\u20133.","journal-title":"Fertil Steril"},{"key":"2185_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fendo.2018.00461","volume":"9","author":"SC Esteves","year":"2018","unstructured":"Esteves SC, Roque M, Bedoschi GM, Conforti A, Humaidan P, Alviggi C. Defining low prognosis patients undergoing assisted reproductive technology: POSEIDON criteria-the why. Front Endocrinol (Lausanne). 2018;9:461.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2185_CR9","doi-asserted-by":"publisher","first-page":"352098","DOI":"10.1155\/2014\/352098","volume":"2014","author":"F Ubaldi","year":"2014","unstructured":"Ubaldi F, Vaiarelli A, D\u2019Anna R, Rienzi L. Management of poor responders in IVF: is there anything new? Biomed Res Int. 2014;2014:352098.","journal-title":"Biomed Res Int"},{"key":"2185_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejogrb.2016.05.027","volume":"203","author":"E Bastu","year":"2016","unstructured":"Bastu E, Buyru F, Ozsurmeli M, Demiral I, Dogan M, Yeh J. A randomized, single-blind, prospective trial comparing three different gonadotropin doses with or without addition of letrozole during ovulation stimulation in patients with poor ovarian response. Eur J Obstet Gynecol Reprod Biol. 2016;203:30\u20134.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"2185_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/09513590.2014.959919","volume":"31","author":"J Haas","year":"2015","unstructured":"Haas J, Zilberberg E, Machtinger R, Kedem A, Hourvitz A, Orvieto R. Do poor-responder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF? Gynecol Endocrinol. 2015;31(1):79\u201382.","journal-title":"Gynecol Endocrinol"},{"issue":"11","key":"2185_CR12","first-page":"CD009749","volume":"26","author":"HE Nagels","year":"2015","unstructured":"Nagels HE, Rishworth JR, Siristatidis CS, Kroon B. Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction. Cochrane Database Syst Rev. 2015;26(11):CD009749.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2185_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.rbmo.2016.11.014","volume":"34","author":"SM Mak","year":"2017","unstructured":"Mak SM, Wong WY, Chung HS, Chung PW, Kong GW, Li TC, et al. Effect of mid-follicular phase recombinant LH vs urinary HCG supplementation in poor ovarian responders undergoing IVF-a prospective double-blinded randomized study. Reprod BioMed Online. 2017;34(3):258\u201366.","journal-title":"Reprod BioMed Online"},{"key":"2185_CR14","doi-asserted-by":"publisher","unstructured":"Cozzolino M. Growth hormone supplementation in women who are not poor responders. J Assist Reprod Genet. 2021. https:\/\/doi.org\/10.1007\/s10815-021-02166-5.","DOI":"10.1007\/s10815-021-02166-5"},{"key":"2185_CR15","doi-asserted-by":"crossref","unstructured":"Cozzolino M, Cecchino GN, Troiano G, Romanelli C. Growth hormone cotreatment for poor responders undergoing in vitro fertilization cycles: a systematic review and meta-analysis. Fertil Steril 2020;15.","DOI":"10.1016\/j.fertnstert.2020.03.007"},{"key":"2185_CR16","first-page":"CD008528","volume":"11","author":"MS Kamath","year":"2017","unstructured":"Kamath MS, Maheshwari A, Bhattacharya S, Lor KY, Gibreel A. Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation. Cochrane Database Syst Rev. 2017;11:CD008528.","journal-title":"Cochrane Database Syst Rev"},{"key":"2185_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejogrb.2019.11.028","volume":"244","author":"M Cozzolino","year":"2020","unstructured":"Cozzolino M, Franasiak J, Andrisani A, Ambrosini G, Vitagliano A. \u201cDelayed start\u201d gonadotropin-releasing hormone antagonist protocol in Bologna poor-responders: a systematic review and meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol. 2020 Jan;244:154\u201362.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"2185_CR18","first-page":"111","volume":"83","author":"L Tutuncu","year":"2012","unstructured":"Tutuncu L, Dundar O. Increasing the stimulation dose of rFHS in unexpected poor responders is not associated with better IVF outcome. Ginekol Pol. 2012 Feb;83(2):111\u20135.","journal-title":"Ginekol Pol"},{"issue":"1","key":"2185_CR19","first-page":"112","volume":"32","author":"MA Youssef","year":"2017","unstructured":"Youssef MA, van Wely M, Al-Inany H, Madani T, Jahangiri N, Khodabakhshi S, et al. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial. Hum Reprod. 2017;32(1):112\u20138.","journal-title":"Hum Reprod"},{"issue":"6","key":"2185_CR20","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.fertnstert.2018.03.019","volume":"109","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2018","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.orgComparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline. Fertil Steril. 2018;109(6):993\u20139.","journal-title":"Fertil Steril"},{"issue":"4","key":"2185_CR21","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.rbmo.2018.07.007","volume":"37","author":"E Labarta","year":"2018","unstructured":"Labarta E, Marin D, Remohi J, Bosch E. Conventional versus minimal ovarian stimulation: an intra-patient comparison of ovarian response in poor-responder women according to Bologna Criteria. Reprod BioMed Online. 2018;37(4):434\u201341.","journal-title":"Reprod BioMed Online"},{"issue":"5","key":"2185_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1447-0756.2005.00320.x","volume":"31","author":"A Sophonsritsuk","year":"2005","unstructured":"Sophonsritsuk A, Choktanasiri W, Weerakiet S, Rojanasakul A. Comparison of outcomes and direct cost between minimal stimulation and conventional protocols on ovarian stimulation in in vitro fertilization. J Obstet Gynaecol Res. 2005;31(5):459\u201363.","journal-title":"J Obstet Gynaecol Res"},{"key":"2185_CR23","doi-asserted-by":"crossref","unstructured":"Cozzolino M, Hervas I, Rivera-Egea R, Pellicer A, Garrido N. Do donor spermatozoa improve reproductive outcomes after oocyte donation failure? A retrospective analysis of cumulative live birth rates per donor oocyte consumed. Reprod Biomed Online 2021 Jan 16.","DOI":"10.1016\/j.rbmo.2021.01.004"},{"issue":"6","key":"2185_CR24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.rbmo.2017.03.003","volume":"34","author":"M Cruz","year":"2017","unstructured":"Cruz M, Alama P, Munoz M, Collado D, Blanes C, Solbes E, et al. Economic impact of ovarian stimulation with corifollitropin alfa versus conventional daily gonadotropins in oocyte donors: a randomized study. Reprod BioMed Online. 2017;34(6):605\u201310.","journal-title":"Reprod BioMed Online"},{"issue":"11","key":"2185_CR25","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1093\/humrep\/dem285","volume":"22","author":"G Nargund","year":"2007","unstructured":"Nargund G, Fauser BC, Macklon NS, Ombelet W, Nygren K, Frydman R, et al. The ISMAAR proposal on terminology for ovarian stimulation for IVF. Hum Reprod. 2007;22(11):2801\u20134.","journal-title":"Hum Reprod"},{"issue":"3","key":"2185_CR26","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0015-0282(99)00584-1","volume":"73","author":"EF Branigan","year":"2000","unstructured":"Branigan EF, Estes MA. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression. Fertil Steril. 2000;73(3):587\u201390.","journal-title":"Fertil Steril"},{"issue":"2","key":"2185_CR27","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S1472-6483(10)60701-8","volume":"15","author":"S Teramoto","year":"2007","unstructured":"Teramoto S, Kato O. Minimal ovarian stimulation with clomiphene citrate: a large-scale retrospective study. Reprod BioMed Online. 2007;15(2):134\u201348.","journal-title":"Reprod BioMed Online"},{"issue":"3","key":"2185_CR28","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/humrep\/deh663","volume":"20","author":"ER Klinkert","year":"2005","unstructured":"Klinkert ER, Broekmans FJ, Looman CW, Habbema JD, te Velde ER. Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial. Hum Reprod. 2005;20(3):611\u20135.","journal-title":"Hum Reprod"},{"issue":"2","key":"2185_CR29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.fertnstert.2017.10.033","volume":"109","author":"MA Youssef","year":"2018","unstructured":"Youssef MA, van Wely M, Mochtar M, Fouda UM, Eldaly A, El Abidin EZ, et al. Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis. Fertil Steril. 2018;109(2):289\u2013301.","journal-title":"Fertil Steril"},{"key":"2185_CR30","doi-asserted-by":"crossref","unstructured":"Datta AK, Maheshwari A, Felix N, Campbell S, Nargund G. Mild versus conventional ovarian stimulation for IVF in poor responders: a systematic review and meta-analysis. Reprod Biomed Online 2020;14.","DOI":"10.1016\/j.rbmo.2020.03.005"},{"key":"2185_CR31","doi-asserted-by":"publisher","first-page":"581451","DOI":"10.1155\/2014\/581451","volume":"2014","author":"T Lazer","year":"2014","unstructured":"Lazer T, Dar S, Shlush E, Al Kudmani BS, Quach K, Sojecki A, et al. Comparison of IVF outcomes between minimal stimulation and high-dose stimulation for patients with poor ovarian reserve. Int J Reprod Med. 2014;2014:581451.","journal-title":"Int J Reprod Med"},{"issue":"1","key":"2185_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1034\/j.1600-0412.2003.820108.x","volume":"82","author":"R Mansour","year":"2003","unstructured":"Mansour R, Aboulghar M, Serour GI, Al-Inany HG, Fahmy I, Amin Y. The use of clomiphene citrate\/human menopausal gonadotrophins in conjunction with GnRH antagonist in an IVF\/ICSI program is not a cost effective protocol. Acta Obstet Gynecol Scand. 2003;82(1):48\u201352.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"2185_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3109\/09513590.2012.730569","volume":"29","author":"IA Mohsen","year":"2013","unstructured":"Mohsen IA, El Din RE. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI. Gynecol Endocrinol. 2013;29(2):105\u20138.","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"2185_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5653\/cerm.2011.38.3.159","volume":"38","author":"JH Yoo","year":"2011","unstructured":"Yoo JH, Cha SH, Park CW, Kim JY, Yang KM, Song IO, et al. Comparison of mild ovarian stimulation with conventional ovarian stimulation in poor responders. Clin Exp Reprod Med. 2011;38(3):159\u201363.","journal-title":"Clin Exp Reprod Med"},{"issue":"7","key":"2185_CR35","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s10815-014-0227-y","volume":"31","author":"A Revelli","year":"2014","unstructured":"Revelli A, Chiado A, Dalmasso P, Stabile V, Evangelista F, Basso G, et al. \u201cMild\u201d vs. \u201clong\u201d protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial. J Assist Reprod Genet. 2014;31(7):809\u201315.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"2185_CR36","first-page":"35","volume":"10","author":"S Pilehvari","year":"2016","unstructured":"Pilehvari S, ShahrokhTehraninejad E, Hosseinrashidi B, Keikhah F, Haghollahi F, Aziminekoo E. Comparison pregnancy outcomes between minimal stimulation protocol and conventional GnRH antagonist protocols in poor ovarian responders. J Family Reprod Health. 2016;10(1):35\u201342.","journal-title":"J Family Reprod Health"},{"key":"2185_CR37","first-page":"1","volume":"2","author":"C Peluso","year":"2020","unstructured":"Peluso C, Oliveira R, Laporta GZ, Christofolini DM, Fonseca FLA, Lagana AS, et al. Are ovarian reserve tests reliable in predicting ovarian response? Results from a prospective, cross-sectional, single-center analysis. Gynecol Endocrinol. 2020;2:1\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"2185_CR38","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00404-018-4906-2","volume":"298","author":"R Di Paola","year":"2018","unstructured":"Di Paola R, Garzon S, Giuliani S, Lagana AS, Noventa M, Parissone F, et al. Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman\u2019s age and markers of ovarian reserve. Arch Gynecol Obstet. 2018;298(5):1029\u201335.","journal-title":"Arch Gynecol Obstet"},{"key":"2185_CR39","doi-asserted-by":"crossref","unstructured":"Ragni G, Levi-Setti PE, Fadini R, Brigante C, Scarduelli C, Alagna F, et al. Clomiphene citrate versus high doses of gonadotropins for in vitro fertilisation in women with compromised ovarian reserve: a randomised controlled non-inferiority trial. Reprod Biol Endocrinol. 2012;10 114-7827-10-114.","DOI":"10.1186\/1477-7827-10-114"},{"issue":"12","key":"2185_CR40","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1093\/humrep\/dex318","volume":"32","author":"TC van Tilborg","year":"2017","unstructured":"van Tilborg TC, Torrance HL, Oudshoorn SC, Eijkemans MJC, Koks CAM, Verhoeve HR, et al. Individualized versus standard FSH dosing in women starting IVF\/ICSI: an RCT. Part 1: the predicted poor responder. Hum Reprod. 2017 Dec 1;32(12):2496\u2013505.","journal-title":"Hum Reprod"}],"updated-by":[{"DOI":"10.1007\/s10815-021-02208-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000}}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-021-02185-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-021-02185-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-021-02185-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T05:23:21Z","timestamp":1627622601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-021-02185-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2185"],"URL":"https:\/\/doi.org\/10.1007\/s10815-021-02185-2","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10815-021-02208-y","asserted-by":"object"}]},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,13]]},"assertion":[{"value":"25 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10815-021-02208-y","URL":"https:\/\/doi.org\/10.1007\/s10815-021-02208-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received ethical approval on 30 November 2018 by IVI Ethic Committee with the number 1810-FIVI-083-MC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}